Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3268298269;98270;98271 chr2:178540122;178540121;178540120chr2:179404849;179404848;179404847
N2AB3104193346;93347;93348 chr2:178540122;178540121;178540120chr2:179404849;179404848;179404847
N2A3011490565;90566;90567 chr2:178540122;178540121;178540120chr2:179404849;179404848;179404847
N2B2361771074;71075;71076 chr2:178540122;178540121;178540120chr2:179404849;179404848;179404847
Novex-12374271449;71450;71451 chr2:178540122;178540121;178540120chr2:179404849;179404848;179404847
Novex-22380971650;71651;71652 chr2:178540122;178540121;178540120chr2:179404849;179404848;179404847
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Fn3-126
  • Domain position: 83
  • Structural Position: 115
  • Q(SASA): 0.2076
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/R None None 1.0 D 0.913 0.744 0.862739897216 gnomAD-4.0.0 1.59657E-06 None None None None N None 0 0 None 0 0 None 0 0 2.87175E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.6298 likely_pathogenic 0.6902 pathogenic -0.418 Destabilizing 1.0 D 0.748 deleterious D 0.559581515 None None N
G/C 0.7125 likely_pathogenic 0.7778 pathogenic -0.822 Destabilizing 1.0 D 0.861 deleterious None None None None N
G/D 0.87 likely_pathogenic 0.9067 pathogenic -0.955 Destabilizing 1.0 D 0.906 deleterious None None None None N
G/E 0.8258 likely_pathogenic 0.8774 pathogenic -1.132 Destabilizing 1.0 D 0.905 deleterious D 0.544604358 None None N
G/F 0.8819 likely_pathogenic 0.9119 pathogenic -1.213 Destabilizing 1.0 D 0.894 deleterious None None None None N
G/H 0.9268 likely_pathogenic 0.9514 pathogenic -0.692 Destabilizing 1.0 D 0.864 deleterious None None None None N
G/I 0.8228 likely_pathogenic 0.8742 pathogenic -0.574 Destabilizing 1.0 D 0.899 deleterious None None None None N
G/K 0.9015 likely_pathogenic 0.9348 pathogenic -0.942 Destabilizing 1.0 D 0.902 deleterious None None None None N
G/L 0.8695 likely_pathogenic 0.9058 pathogenic -0.574 Destabilizing 1.0 D 0.876 deleterious None None None None N
G/M 0.9025 likely_pathogenic 0.9299 pathogenic -0.42 Destabilizing 1.0 D 0.861 deleterious None None None None N
G/N 0.8495 likely_pathogenic 0.8843 pathogenic -0.532 Destabilizing 1.0 D 0.844 deleterious None None None None N
G/P 0.9953 likely_pathogenic 0.9955 pathogenic -0.489 Destabilizing 1.0 D 0.901 deleterious None None None None N
G/Q 0.8515 likely_pathogenic 0.891 pathogenic -0.89 Destabilizing 1.0 D 0.911 deleterious None None None None N
G/R 0.8542 likely_pathogenic 0.9005 pathogenic -0.411 Destabilizing 1.0 D 0.913 deleterious D 0.559835004 None None N
G/S 0.4972 ambiguous 0.5685 pathogenic -0.622 Destabilizing 1.0 D 0.841 deleterious None None None None N
G/T 0.78 likely_pathogenic 0.8257 pathogenic -0.745 Destabilizing 1.0 D 0.903 deleterious None None None None N
G/V 0.7834 likely_pathogenic 0.8449 pathogenic -0.489 Destabilizing 1.0 D 0.889 deleterious D 0.535400873 None None N
G/W 0.9066 likely_pathogenic 0.9316 pathogenic -1.343 Destabilizing 1.0 D 0.869 deleterious None None None None N
G/Y 0.877 likely_pathogenic 0.9118 pathogenic -1.014 Destabilizing 1.0 D 0.893 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.